Blog

Discover the role of IgG antibodies in immune defense, pathogen neutralization, and placental immunity, and learn about IgG subclasses (IgG1–IgG4) and their distinct functions.

HAMA responses can disrupt assays and diagnostics. Learn why they arise, their impact on research, and practical strategies to avoid misleading results.

Explore the benefits and limitations of monoclonal antibodies, including high specificity, broad research and clinical applications, production costs, and therapeutic challenges.

Speed drives better decisions. Discover how high-throughput recombinant antibody production shortens design-test cycles and accelerates research pipelines worldwide.

Learn how antibody optimization techniques like humanization, deimmunization, affinity maturation & Fc engineering improve therapeutic antibodies.

Explore ethical questions around antibody production in animals, the 3Rs principle, and how recombinant technology reduces animal use while ensuring high-quality science.

Explore how monoclonal antibodies combat COVID-19 by neutralizing SARS-CoV-2, including therapies like Actemra, challenges from emerging variants and Biointron’s antibody research.

Learn how antibodies enable protein–protein interaction research using immunofluorescence, immunoprecipitation and co-immunoprecipitation to study signaling pathways and complexes.

Stability makes or breaks biologics. Understand drivers of aggregation, fragmentation, and chemical change—and the formulation tactics that protect quality.

Learn the differences between polyclonal and monoclonal antibodies, including production methods, advantages, limitations, and research or therapeutic applications.

Antibody‑drug conjugates unite precise targeting with potent payloads. Explore linkers, payload classes, DAR control, and the levers that improve efficacy and safety.

Discover advancements in antibody engineering, from bispecific formats to Fc optimization and humanization, driving innovation in next-generation therapeutic antibody development.